{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:14:34Z","timestamp":1761110074557},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.medcli.2012.12.015","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T16:34:39Z","timestamp":1361464479000},"page":"33-36","source":"Crossref","is-referenced-by-count":2,"title":["Aplicaciones de la toxina botul\u00ednica en Neurolog\u00eda"],"prefix":"10.1016","volume":"141","author":[{"given":"Pedro J.","family":"Garcia-Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2012.12.015_bib0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tins.2005.06.001","article-title":"Beyond BOTOX: Advantages and limitations of individual botulinum neurotoxins","volume":"28","author":"Davletov","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.medcli.2012.12.015_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2004-830901","article-title":"Botulism: Update and review","volume":"24","author":"Cherington","year":"2004","journal-title":"Semin Neurol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archneurpsyc.1947.02300280072004","article-title":"Physiology of botulinum toxin","volume":"57","author":"Guyton","year":"1947","journal-title":"Arch Neurol Psychiatry"},{"key":"10.1016\/j.medcli.2012.12.015_bib0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1353\/pbm.1997.0032","article-title":"Botulinum toxin: The history of its development for the treatment of human disease","volume":"40","author":"Schantz","year":"1997","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.medcli.2012.12.015_bib0025","first-page":"924","article-title":"Pharmacological weakening of extraocular muscles","volume":"12","author":"Scott","year":"1973","journal-title":"Invest Ophthalmol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3928\/0191-3913-19800101-06","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"17","author":"Scott","year":"1980","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.medcli.2012.12.015_bib0035","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S1474-4422(06)70547-6","article-title":"The diagnosis of dystonia","volume":"5","author":"Geyer","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0040","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0002-9394(14)77954-1","article-title":"The use of botulinum toxin in blepharospasm","volume":"99","author":"Shorr","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0045","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","article-title":"Blepharospasm: A review of 264 patients","volume":"51","author":"Grandas","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.medcli.2012.12.015_bib0050","first-page":"583","article-title":"Blepharospasm and oromandibular-laryngeal-cervical dystonia: A controlled trial of botulinum A toxin therapy","volume":"50","author":"Jankovic","year":"1988","journal-title":"Adv Neurol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2012.12.015_bib0060","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.medcli.2012.12.015_bib0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/mds.870060210","article-title":"Treatment of idiopathic spasmodic torticollis with botulinum toxin A: A double-blind study on twenty-three patients","volume":"6","author":"Lorentz","year":"1991","journal-title":"Mov Disord"},{"key":"10.1016\/j.medcli.2012.12.015_bib0070","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","article-title":"A new botulinum toxin type A free of complexing proteins for cervical dystonia","volume":"64","author":"Benecke","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.medcli.2012.12.015_bib0075","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00415-010-5880-1","article-title":"Evolution of dose and response to botulinum toxin A in cervical dystonia: A multicenter study","volume":"258","author":"Ruiz","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0080","first-page":"599","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm","volume":"50","author":"Brin","year":"1988","journal-title":"Adv Neurol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0085","first-page":"196","article-title":"Botulinum toxin treatment for spasmodic dysphonia: Percutaneous versus transoral approach","volume":"21","author":"Garc\u00eda Ruiz","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00839202","article-title":"Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin","volume":"239","author":"Lees","year":"1992","journal-title":"J Neurol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0095","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/jnnp.2005.083170","article-title":"Botulinum toxin for writer's cramp: A randomised, placebo-controlled trial and 1-year follow-up","volume":"78","author":"Kruisdijk","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.medcli.2012.12.015_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21091\/mppa.2010.1002","article-title":"Focal dystonia in musicians: Phenomenology, pathophysiology, triggering factors, and treatment","volume":"25","author":"Altenm\u00fcller","year":"2010","journal-title":"Med Probl Perform Art"},{"key":"10.1016\/j.medcli.2012.12.015_bib0105","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/WNL.46.4.1066","article-title":"Botulinum toxin versus trihexyphenidyl in cervical dystonia: A prospective, randomized, double-blind controlled trial","volume":"46","author":"Brans","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.medcli.2012.12.015_bib0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01241398-199405000-00005","article-title":"Management of spasticity in cerebral palsy with botulinum-A toxin: Report of a preliminary, randomized, double-blind trial","volume":"14","author":"Koman","year":"1994","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.medcli.2012.12.015_bib0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1469-8749.1997.tb07408.x","article-title":"Botulinum toxin A in the hemiplegic upper limb: A double-blind trial","volume":"39","author":"Corry","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0120","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/jnnp.2008.159657","article-title":"Botulinum neurotoxin versus tizanidine in upper limb spasticity: A placebo-controlled study","volume":"80","author":"Simpson","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.medcli.2012.12.015_bib0125","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1185\/03007995.2010.497103","article-title":"Botulinum toxin type A in post-stroke upper limb spasticity","volume":"26","author":"Kaji","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.medcli.2012.12.015_bib0130","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/STROKEAHA.110.582197","article-title":"Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: Effect on impairment, activity limitation, and pain","volume":"42","author":"Shaw","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.medcli.2012.12.015_bib0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1468-1331.2000.00043.x","article-title":"Progressive response to botulinum A toxin in cerebral palsy","volume":"7","author":"Garc\u00eda Ruiz","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0140","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/jnnp.2006.103341","article-title":"Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: A randomised, double blind, placebo controlled study of botulinum toxin A","volume":"78","author":"Yelnik","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.medcli.2012.12.015_bib0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2011.11.001","article-title":"Neurotherapeutics to inhibit exocytosis from sensory neurons for the control of chronic pain","volume":"12","author":"Dolly","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.pediatrneurol.2010.06.001","article-title":"Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache","volume":"43","author":"Ahmed","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0155","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.2012.505","article-title":"Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: A meta-analysis","volume":"307","author":"Jackson","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2012.12.015_bib0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/PHM.0b013e3181bc0c78","article-title":"Effect of botulinum toxin injection on nocturnal bruxism: A randomized controlled trial","volume":"89","author":"Lee","year":"2010","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.medcli.2012.12.015_bib0165","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.joms.2003.04.014","article-title":"Recurrent temporomandibular joint dislocation treated with botulinum toxin: Report of 3 cases","volume":"62","author":"Mart\u00ednez-P\u00e9rez","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.medcli.2012.12.015_bib0170","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.wco.0000280411.57836.aa","article-title":"Treatment of sialorrhoea in patients with Parkinson's disease: Best current evidence","volume":"20","author":"Molloy","year":"2007","journal-title":"Curr Opin Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.medcli.2012.12.015_bib0175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1468-1331.2010.03131.x","article-title":"Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: International consensus statement","volume":"17","author":"Reddihough","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(03)00307-7","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"2","author":"Pfeiffer","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.medcli.2012.12.015_bib0185","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.parkreldis.2011.01.007","article-title":"Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients","volume":"17","author":"Gil","year":"2011","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T17:07:45Z","timestamp":1595437665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775313000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0025775313000110"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2012.12.015","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}